Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CLVS - Clovis rises 7% after signing supply agreement with NorthStar Medical for therapeutic actinium-225

CLVS - Clovis rises 7% after signing supply agreement with NorthStar Medical for therapeutic actinium-225

Clovis Oncology Inc.
  • NorthStar Medical said it had signed a long term supply agreement with Clovis Oncology ( CLVS ) for the therapeutic medical radioisotope, actinium-225 ((AC-225)).
  • Clovis plans to use NorthStar's Ac-225 to radiolabel its lead therapeutic candidate currently in development, FAP-2286, which targets fibroblast activation protein, a promising theranostic target with expression across many tumor types.
  • NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that manufactures and distributes diagnostic and therapeutic radiopharmaceuticals.
  • ( CLVS ) is up about 7% before the bell.

For further details see:

Clovis rises 7% after signing supply agreement with NorthStar Medical for therapeutic actinium-225
Stock Information
Company Name: Clovis Oncology Inc.
Stock Symbol: CLVS
Market: NASDAQ
Website: clovisoncology.com
Menu
CLVS CLVS Quote CLVS Short CLVS News CLVS Articles CLVS Message Board
Get CLVS Alerts

News, Short Squeeze, Breakout and More Instantly...